Morning Read: KaloBios faces delisting; Leidos gets extra DoD EHR contract
Plus, Kentucky settles marketing cases with J&J and Purdue Pharma, while a family doc shares a Christmas EHR wish list.
Morning Read: Martin Shkreli takes over KaloBios, is a more powerful brand than the Kardashians
Plus, NIH ends support for invasive research on chimpanzees and Sanofi and AstraZeneca said they had agreed a direct exchange of 210,000 chemical compounds.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.